Taken together, our results show that combined PI3K activation and p53 loss faithfully reproduce the development of thyroid anaplastic carcinomas, and provide a compelling rationale for targeting glycolysis to increase chemotherapy response in ATC patients. Here, TP53 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.